DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
7.10
-0.40 (-5.33%)
Jul 29, 2026, 4:00 PM EDT - Market closed
DarioHealth Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, DarioHealth stock has a consensus rating of "Buy" and an average price target of $18.5. The average 1-year stock price forecast is 160.56% higher than the current stock price, while the lowest is $10 (+40.85%) and the highest is $28 (+294.37%).
Price Target: $18.5 (+160.56%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 15, 2026.
Analyst Ratings
The average analyst rating for DarioHealth stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $10 | Buy | Maintains | $10 | +40.85% | May 15, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $11 | Hold | Maintains | $11 | +54.93% | May 13, 2026 |
Financial Forecast
Revenue This Year
26.29M
from 22.36M
Increased by 17.60%
Revenue Next Year
38.77M
from 26.29M
Increased by 47.46%
EPS This Year
-2.81
from -7.33
EPS Next Year
-0.68
from -2.81
EPS and Forward PE are based on non-GAAP adjusted numbers.